FOREST LAKE, MN (Sept. 15, 2026) – Velosity has acquired Lucid Labs, an advanced engineering and precision machining company, expanding its ability to support the medical device industry from early product development through commercialization. The acquisition brings product development, engineering and rapid prototyping expertise together with Velosity’s established manufacturing capabilities, creating a more connected path from concept to market.
Based in Rogers, Minn., Lucid Labs has been a trusted development partner to leading medtech original equipment manufacturers (OEMs) for more than 20 years, helping accelerate the design, development and commercialization of innovative medical technologies. The acquisition expands Velosity’s ability to engage with customers earlier in the product development cycle, helping guide products from concept development and prototyping through manufacturing and commercialization. With embedded engineering support working directly alongside customer teams, Velosity can now help evaluate designs, develop and refine prototypes, address manufacturability considerations, and prepare products for production.
“Our goal has always been to accelerate innovation for our customers,” said Dave Hemink, CEO of Velosity. “The addition of Lucid Labs expands our ability to engage earlier, solve complex challenges and support customers throughout the product lifecycle, creating a more connected path to commercialization and a much deeper understanding of strategy and portfolio trajectory.”
The transaction also expands the capabilities of the Velosity Engineering, Launch and Optimization Lab™ through Lucid’s rapid prototyping capabilities. As part of the transaction, Lucid founder and CEO Tim Hillukka will join Velosity as Chief Innovation Officer, leading ideation and innovation across the combined customer base.
“Joining Velosity creates a unique opportunity to combine Lucid’s innovative, industry-leading product development expertise with world-class manufacturing capabilities,” Hillukka said. “We are engaging with customers sooner, solving more complex challenges, and delivering innovative medical technologies to the market faster.”
A More Connected Path to Commercialization
Velosity’s expanded services give medical device companies more opportunities to engage with engineering and manufacturing teams earlier in the development process. By bringing these disciplines together, customers can evaluate designs, refine prototypes, address manufacturability considerations and prepare devices for production with greater continuity.
“Bringing Lucid Labs together with Velosity creates a connected path from concept to commercialization,” said Darren Bjork, Chief Commercial Officer at Velosity. “Together, we can help customers solve challenges earlier, accelerate development and transition more seamlessly into manufacturing, helping innovative technologies reach clinicians and patients sooner.”
The expanded services include:
Product Development: Concept development, product design support, design optimization and manufacturing readiness.
Embedded Engineering Services: Mechanical engineering, design for manufacturability, fixture design, process development and product optimization.
Rapid Prototyping: CNC and Swiss machining, 3D printing, production-quality prototypes, functional prototypes and short-run manufacturing.
These new services complement Velosity’s established expertise in tooling, injection molding, precision machining, assembly and packaging, giving customers more ways to engage Velosity as their products move from development and prototyping into manufacturing readiness and full-scale production.
For more information about Velosity, visit Velosity.com.